Elicio Therapeutics, Inc.
ELTX
$10.60
-$0.43-3.90%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.95M | 11.61M | 11.33M | 11.80M | 12.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.65M | 45.48M | 44.99M | 40.90M | 41.33M |
| Operating Income | -44.65M | -45.48M | -44.99M | -40.90M | -41.33M |
| Income Before Tax | -54.61M | -51.28M | -51.90M | -46.84M | -38.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.61 | -51.28 | -51.90 | -46.84 | -38.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.61M | -51.28M | -51.90M | -46.84M | -38.66M |
| EBIT | -44.65M | -45.48M | -44.99M | -40.90M | -41.33M |
| EBITDA | -44.38M | -45.19M | -44.66M | -40.59M | -41.00M |
| EPS Basic | -3.94 | -3.92 | -4.20 | -4.23 | -4.11 |
| Normalized Basic EPS | -2.48 | -2.45 | -2.63 | -2.65 | -2.57 |
| EPS Diluted | -3.94 | -3.92 | -4.20 | -4.23 | -4.11 |
| Normalized Diluted EPS | -2.48 | -2.45 | -2.63 | -2.65 | -2.57 |
| Average Basic Shares Outstanding | 56.24M | 51.47M | 48.79M | 43.68M | 38.48M |
| Average Diluted Shares Outstanding | 56.24M | 51.47M | 48.79M | 43.68M | 38.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |